This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Hartmut Stagelmeier: Innovator in Circulatory Agents
Introduction
Hartmut Stagelmeier is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of circulatory agents. His work has implications for improving cardiovascular health and enhancing the efficacy of treatments.
Latest Patents
Stagelmeier holds a patent for "Amino-esters of dihydropyridines, and their use as circulatory agents." This patent describes circulation-active compounds of the formula ##STR1##, where R.sup.1 is phenyl or heterocyclyl substituted by nitro, trifluoromethyl, or other radicals. This innovation represents a step forward in the search for effective circulatory agents.
Career Highlights
Throughout his career, Hartmut Stagelmeier has been associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Stagelmeier has worked alongside notable colleagues such as Eckhard Schwenner and Stanislav Kazda. These collaborations have fostered an environment of innovation and have led to advancements in the development of new therapeutic agents.
Conclusion
Hartmut Stagelmeier's contributions to the field of circulatory agents highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile